Superintendent pharmacist of Manor Pharmacy Group. Graham Phillips is a second-generation pharmacist, and Managing Director of the award-winning Manor Pharmacy Group, of seven pharmacies in Hertfordshire one in Kent. Qualifying in 1982, his increasing interest in extended pharmacy roles led him to undertake a post-graduate clinical diploma at what is now known as King’s College School of Pharmacy in 1997. Having completed his diploma he now enjoys strong practice and research links with the School of Pharmacy, University of Hertfordshire. Working collaboratively with the School, Graham has developed the “teaching pharmacy” concept – the pharmacy equivalent of the GP Teaching Practice. This has borne significant fruit resulting most recently in the publication of a paper on the role of community pharmacy in Type-2 diabetes. He has worked with GPs and in Primary Care widely for fifteen years, including as a PCT Prescribing Lead, and PEC and Board member. He wants to see much-closer working relationships with GPs. He has been involved in pharmacy politics at local and national level, for 15 years including four years on the Council of the RPSGB – three as chair of the Education Committee. He sat on the RPS English Pharmacy Board. Graham has had a long-term interest in Public Health: he has been involved with NHS cancer-reform strategy and sits on the board of the National Obesity Forum. He was also a member of the Healthy Living Pharmacy reference group. Manor Pharmacy Group has won a numerous local and national awards – notably they were runners-up in the PJ “Care Awards” 2009. In November 2012 Graham was awarded “Leader of the Year” at the Pharmacy Business awards; Sameena Ashraf, one of Manor Pharmacy Group’s latest cohort, was awarded “Pre Registration Trainee of the Year” at the same awards. Graham was made a Fellow of the RPSGB in 2009.
I hope colleagues will forgive my reference to the Theresa May rhetoric, but as a community pharmacist I have to ask, is the SalvaDore (RPS) really working for me? It seems that the RPS is obsessed with the practice pharmacist initiative (which, I agree, is excellent) but the implementation to date has been to benefit the few (2,000 practice pharmacists) at the expense of the many (around 30,000 community pharmacists). The RPS has a shiny new website and I searched t
I recently attended the ‘Quality for patients: pharmacy practice now and in the future’ conference on 22 March 2017, hosted by NHS England. I was looking forward to a positive, constructive day celebrating and showcasing all that is best among our profession, but I came away appalled by the attitude of the chief pharmaceutical officer for England, Keith Ridge. During his 20-minute presentation he praised, one-by-one, every sector of pharmacy for its clinical excellence barring any ment
Just before Christmas, I was appalled at the fait accompli decision announced with such callous disregard for our profession to slash the funding of community pharmacy by £170m (6%) in 2016–2017. As the funding reduction will not kick in until September 2016, this effectively means pharmacies will see a net 12% reduction in their NHS income in the second half of the financial year. Alistair Burt, the pharmacy minister, announced the government’s intention to close 3
No more pro-pharmacy rhetoric: we need actionSubscription
Recent blog posts
The more I learn of the new inspection model the more concerned I become.